David Hess

Tress Capital

Co-Founder and President

David Hess is a career entrepreneur with a unique relationship to cannabis for the past two decades. A two time cancer survivor, David was introduced to the vast benefits of medical cannabis while undergoing cancer treatments in 2001 and again in 2003. David has since dedicated himself to furthering research, awareness, impact and business opportunities in the expanding cannabis industry. In 2013, David partnered with Asher Troppe, an experienced fiduciary and independent trader on Wall Street with over a decade's experience managing equity portfolios to establish Tress, the cannabis industry’s go to source for private capital, solutions and strategic support. Tress Capital is a strategic boutique private investment firm embedded at the core of the global cannabis sector originating and managing investments for HNW, family office, and institutional investors. Tress has a track record of successful industry investment and works closely with its companies and the industry providing active value-add support. The Tress portfolio includes impactful industry leaders such as SC Labs, Headset, TILT (by way of Baker Technologies), Cannabis Now, Grownetics, North Bud Farms, Infusion Biosciences, WasteTrakr and iCAN. With a unique industry network, unparalleled deal flow pipeline, successful portfolio investment track record and an experienced team with in house niche expertise, Tress Capital is the go to for sophisticated investors seeking competence while Tress Solutions provides M&A advisory, strategy, business development, and operational support to sector companies.

Friday, October 9, 2020

12:00 PM - 1:00 PM MDT

Sustainable Cannabis Investment Markets

Join on Zoom

Cannabis_1 - Zoom 6

Panel Business

David Hess

Tress Capital, Co-Founder and President

Emily Paxhia

Poseidon, Co-Founder & Managing Partner

Troy Dayton

Coleman Beale

CEO and Board Member

It's not often that an entirely new legal industry springs up practically overnight after having been mostly illegal for decades. Unlike most emerging industries, cannabis already has a long-established consumer base for both recreational and medical uses, raising the question of how fast and how big the industry will grow, and what ethics will emerge from the start. There are also significant sustainability risks in the cannabis industry that potentially threaten its success. Investors should consider these risks as they evaluate their investments. This panel will review some of these risks, and discuss how investors can leverage their financial power to push to cannabis industry towards a more sustainable future.